LEDIPASVIR vs LENVATINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
LEDIPASVIR vs LENVATINIB: Safety Overview
| Metric | LEDIPASVIR | LENVATINIB |
|---|---|---|
| Total FAERS Reports | 516 | 33,766 |
| Deaths Reported | 304 | 4,449 |
| Death Rate | 58.9% | 13.2% |
| Hospitalizations | 34 | 19,975 |
| Average Patient Age | 58.5 yrs | 65.4 yrs |
| % Female Patients | 29.5% | 55.8% |
| FDA Approval Date | N/A | Feb 13, 2015 |
| Manufacturer | Gilead Sciences, Inc | Eisai Inc. |
| Route | ORAL | ORAL |
| Marketing Status | N/A | Prescription |